Glaukos Corporation vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
5.8
Neutral
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
GKOS
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ currently unprofitable (-34% margin).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $151.08 (+7.7%)
12 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
GKOS
PFE
—
Trailing P/E
19.4×
293.1×
Forward P/E
9.4×
-34.3%
Profit Margin
12.4%
78.1%
Gross Margin
75.8%
-26.4%
ROE
8.9%
41.2%
Revenue Growth
-1.2%
—
Earnings Growth
—
0.78
Beta
0.39
—
Price / Book
—
$8.2B
Market Cap
$149.8B
$73 – $147
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →